|
FOLLOW-UP |
Variable |
Base line |
One year follow |
Two years follow |
Three years follow |
|
RR |
P |
RR |
P |
RR |
P |
RR |
P |
Gender |
0.823 (0.487-1.390) |
0.466 |
1.200 (0.719-2.001) |
0.486 |
1.250 (0.756-2.068) |
0.385 |
1.189 (0.724-1.954) |
0.494 |
Age (years) |
1.086 (1.043-1.131) |
<0.001 |
1.073 (1.034-1.114) |
<0.001 |
1.073 (1.035-1.113) |
<0.001 |
1.073 (1.036-1.112) |
<0.001 |
T2DM Evolution (y) |
0.978 (0.908-1.053) |
0.555 |
0.990 (0.921-1.060) |
0.772 |
1.017 (0.950-1.088) |
0.630 |
1.016 (0.951-1.086) |
0.637 |
Heterozygous (D/I) |
0.509 (0.302-0.857) |
0.011 |
0.569 (0.342-0.945) |
0.029 |
0.555 (0.337-0.916) |
0.021 |
0.557 (0.340-0.913) |
0.020 |
Homozygous (D/D) |
1.742 (1.004-3.025) |
0.048 |
0.648 (0.377-1.114) |
0.116 |
0.595 (0.349-1.015) |
0.057 |
0.602 (0.355-1.022) |
0.060 |
Homozygous (I/I) |
1.402 (0.639-3.075) |
0.399 |
1.409 (0.652-3.044) |
0.383 |
1.263 (0.568-2.725) |
0.551 |
1.300 (0.609-2.776) |
0.498 |
|
| Table 4: Variables related with DPN presence during follow-up. RR: Relative Risk, CI: confidence interval. |
